APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Vigilance Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Vigilance Solutions Market Outlook and Growth Opportunities 2026

3 May 2026195 pages

Choose your research edition.

Industry ResearchMedical Vigilance Solutions Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Vigilance Solutions Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Medical Vigilance Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Vigilance Solutions Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Vigilance Solutions Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Medical Vigilance Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Vigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Vigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Vigilance Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Vigilance Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Vigilance Solutions market include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA and Parexel, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Vigilance Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Vigilance Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Vigilance Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Vigilance Solutions market.

Medical Vigilance Solutions Segment by Company

Eurofins Scientific

Accenture

PPD

SGS

WuXi AppTec

Cognizant

ICON

IQVIA

Parexel

United BioSource

Vial

Wipro

PrimeVigilance

Aixial Group

TransPerfect

ProPharma

HCLTech

QbD Group

Quanticate

Qinecsa Solutions

Veristat

Veeda

Tigermed

Clarivate

Medical Vigilance Solutions Segment by Type

Writing and Submitting Documents and Reports

Security Database System Services and Data Management

Signal Detection and Evaluation

Training and Consulting

Other

Medical Vigilance Solutions Segment by Application

Clinical

Non-clinical

Medical Vigilance Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Vigilance Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Vigilance Solutions key companies, revenue, market share, and recent developments.

3. To split the Medical Vigilance Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Vigilance Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Vigilance Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Vigilance Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Vigilance Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Vigilance Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Vigilance Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Vigilance Solutions industry.

Chapter 3: Detailed analysis of Medical Vigilance Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Vigilance Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Vigilance Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Vigilance Solutions Industry Trends Table 2. Medical Vigilance Solutions Industry Drivers Table 3. Medical Vigilance Solutions Industry Opportunities and Challenges Table 4. Medical Vigilance Solutions Industry Restraints Table 5. Global Medical Vigilance Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Vigilance Solutions Revenue Share by Company (2021-2026) Table 7. Global Medical Vigilance Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Vigilance Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Medical Vigilance Solutions Company, Product Type & Application Table 10. Global Medical Vigilance Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Vigilance Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Writing and Submitting Documents and Reports Table 15. Significant Companies of Security Database System Services and Data Management Table 16. Significant Companies of Signal Detection and Evaluation Table 17. Significant Companies of Training and Consulting Table 18. Significant Companies of Other Table 19. Global Medical Vigilance Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Medical Vigilance Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Medical Vigilance Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Medical Vigilance Solutions Sales Value Share by Type (2021-2026) Table 23. Global Medical Vigilance Solutions Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Clinical Table 25. Significant Companies of Non-clinical Table 26. Global Medical Vigilance Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Vigilance Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Medical Vigilance Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Medical Vigilance Solutions Sales Value Share by Application (2021-2026) Table 30. Global Medical Vigilance Solutions Sales Value Share by Application (2027-2032) Table 31. Global Medical Vigilance Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Vigilance Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Medical Vigilance Solutions Sales Value Share by Region (2021-2026) Table 34. Global Medical Vigilance Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Medical Vigilance Solutions Sales Value Share by Region (2027-2032) Table 36. Global Medical Vigilance Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Medical Vigilance Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Medical Vigilance Solutions Sales Value Market Share by Country (2021-2026) Table 39. Global Medical Vigilance Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Medical Vigilance Solutions Sales Value Market Share by Country (2027-2032) Table 41. Eurofins Scientific Company Information Table 42. Eurofins Scientific Business Overview Table 43. Eurofins Scientific Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Eurofins Scientific Medical Vigilance Solutions Product Portfolio Table 45. Eurofins Scientific Recent Development Table 46. Accenture Company Information Table 47. Accenture Business Overview Table 48. Accenture Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Accenture Medical Vigilance Solutions Product Portfolio Table 50. Accenture Recent Development Table 51. PPD Company Information Table 52. PPD Business Overview Table 53. PPD Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. PPD Medical Vigilance Solutions Product Portfolio Table 55. PPD Recent Development Table 56. SGS Company Information Table 57. SGS Business Overview Table 58. SGS Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. SGS Medical Vigilance Solutions Product Portfolio Table 60. SGS Recent Development Table 61. WuXi AppTec Company Information Table 62. WuXi AppTec Business Overview Table 63. WuXi AppTec Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. WuXi AppTec Medical Vigilance Solutions Product Portfolio Table 65. WuXi AppTec Recent Development Table 66. Cognizant Company Information Table 67. Cognizant Business Overview Table 68. Cognizant Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Cognizant Medical Vigilance Solutions Product Portfolio Table 70. Cognizant Recent Development Table 71. ICON Company Information Table 72. ICON Business Overview Table 73. ICON Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. ICON Medical Vigilance Solutions Product Portfolio Table 75. ICON Recent Development Table 76. IQVIA Company Information Table 77. IQVIA Business Overview Table 78. IQVIA Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. IQVIA Medical Vigilance Solutions Product Portfolio Table 80. IQVIA Recent Development Table 81. Parexel Company Information Table 82. Parexel Business Overview Table 83. Parexel Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Parexel Medical Vigilance Solutions Product Portfolio Table 85. Parexel Recent Development Table 86. United BioSource Company Information Table 87. United BioSource Business Overview Table 88. United BioSource Medical Vigilance Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. United BioSource Medical Vigilance Solutions Product Portfolio Table 90. United BioSource Recent Development Table 91. Vial Company Information Table 92. Vial Business Overview Table 93. Vial Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Vial Medical Vigilance Solutions Product Portfolio Table 95. Vial Recent Development Table 96. Wipro Company Information Table 97. Wipro Business Overview Table 98. Wipro Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Wipro Medical Vigilance Solutions Product Portfolio Table 100. Wipro Recent Development Table 101. PrimeVigilance Company Information Table 102. PrimeVigilance Business Overview Table 103. PrimeVigilance Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. PrimeVigilance Medical Vigilance Solutions Product Portfolio Table 105. PrimeVigilance Recent Development Table 106. Aixial Group Company Information Table 107. Aixial Group Business Overview Table 108. Aixial Group Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Aixial Group Medical Vigilance Solutions Product Portfolio Table 110. Aixial Group Recent Development Table 111. TransPerfect Company Information Table 112. TransPerfect Business Overview Table 113. TransPerfect Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. TransPerfect Medical Vigilance Solutions Product Portfolio Table 115. TransPerfect Recent Development Table 116. ProPharma Company Information Table 117. ProPharma Business Overview Table 118. ProPharma Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. ProPharma Medical Vigilance Solutions Product Portfolio Table 120. ProPharma Recent Development Table 121. HCLTech Company Information Table 122. HCLTech Business Overview Table 123. HCLTech Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. HCLTech Medical Vigilance Solutions Product Portfolio Table 125. HCLTech Recent Development Table 126. QbD Group Company Information Table 127. QbD Group Business Overview Table 128. QbD Group Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. QbD Group Medical Vigilance Solutions Product Portfolio Table 130. QbD Group Recent Development Table 131. Quanticate Company Information Table 132. Quanticate Business Overview Table 133. Quanticate Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Quanticate Medical Vigilance Solutions Product Portfolio Table 135. Quanticate Recent Development Table 136. Qinecsa Solutions Company Information Table 137. Qinecsa Solutions Business Overview Table 138. Qinecsa Solutions Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Qinecsa Solutions Medical Vigilance Solutions Product Portfolio Table 140. Qinecsa Solutions Recent Development Table 141. Veristat Company Information Table 142. Veristat Business Overview Table 143. Veristat Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Veristat Medical Vigilance Solutions Product Portfolio Table 145. Veristat Recent Development Table 146. Veeda Company Information Table 147. Veeda Business Overview Table 148. Veeda Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Veeda Medical Vigilance Solutions Product Portfolio Table 150. Veeda Recent Development Table 151. Tigermed Company Information Table 152. Tigermed Business Overview Table 153. Tigermed Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Tigermed Medical Vigilance Solutions Product Portfolio Table 155. Tigermed Recent Development Table 156. Clarivate Company Information Table 157. Clarivate Business Overview Table 158. Clarivate Medical Vigilance Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Clarivate Medical Vigilance Solutions Product Portfolio Table 160. Clarivate Recent Development Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Medical Vigilance Solutions Product Image Figure 2. Global Medical Vigilance Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Vigilance Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Vigilance Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Writing and Submitting Documents and Reports Image Figure 8. Security Database System Services and Data Management Image Figure 9. Signal Detection and Evaluation Image Figure 10. Training and Consulting Image Figure 11. Other Image Figure 12. Global Medical Vigilance Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Medical Vigilance Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Medical Vigilance Solutions Sales Value Share by Type (2021-2032) Figure 15. Clinical Image Figure 16. Non-clinical Image Figure 17. Global Medical Vigilance Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical Vigilance Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Medical Vigilance Solutions Sales Value Share by Application (2021-2032) Figure 20. Global Medical Vigilance Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Medical Vigilance Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Medical Vigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 23. North America Medical Vigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Medical Vigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Medical Vigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Medical Vigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Medical Vigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Medical Vigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 29. South America Medical Vigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Medical Vigilance Solutions Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Medical Vigilance Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Medical Vigilance Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Writing and Submitting Documents and Reports
  • Security Database System Services and Data Management
  • Signal Detection and Evaluation
  • Training and Consulting
  • Other
Applications
  • Clinical
  • Non-clinical
Companies covered
  • Eurofins Scientific
  • Accenture
  • PPD
  • SGS
  • WuXi AppTec
  • Cognizant
  • ICON
  • IQVIA
  • Parexel
  • United BioSource
  • Vial
  • Wipro
  • PrimeVigilance
  • Aixial Group
  • TransPerfect
  • ProPharma
  • HCLTech
  • QbD Group
  • Quanticate
  • Qinecsa Solutions
  • Veristat
  • Veeda
  • Tigermed
  • Clarivate

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Vigilance Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Vigilance Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Vigilance Solutions Market Dynamics
  1. 2.1 Medical Vigilance Solutions Industry Trends
  2. 2.2 Medical Vigilance Solutions Industry Drivers
  3. 2.3 Medical Vigilance Solutions Industry Opportunities and Challenges
  4. 2.4 Medical Vigilance Solutions Industry Restraints
3 Medical Vigilance Solutions Market by Company
  1. 3.1 Global Medical Vigilance Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Medical Vigilance Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Medical Vigilance Solutions Company Ranking (2024-2026)
  4. 3.4 Global Medical Vigilance Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Vigilance Solutions Company Product Type and Application
  6. 3.6 Global Medical Vigilance Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Vigilance Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Vigilance Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Vigilance Solutions Market by Type
  1. 4.1 Medical Vigilance Solutions Type Introduction
  2. 4.1.1 Writing and Submitting Documents and Reports
  3. 4.1.2 Security Database System Services and Data Management
  4. 4.1.3 Signal Detection and Evaluation
  5. 4.1.4 Training and Consulting
  6. 4.1.5 Other
  7. 4.2 Global Medical Vigilance Solutions Sales Value by Type
  8. 4.2.1 Global Medical Vigilance Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Medical Vigilance Solutions Sales Value by Type (2021-2032)
  10. 4.2.3 Global Medical Vigilance Solutions Sales Value Share by Type (2021-2032)
5 Medical Vigilance Solutions Market by Application
  1. 5.1 Medical Vigilance Solutions Application Introduction
  2. 5.1.1 Clinical
  3. 5.1.2 Non-clinical
  4. 5.2 Global Medical Vigilance Solutions Sales Value by Application
  5. 5.2.1 Global Medical Vigilance Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Medical Vigilance Solutions Sales Value by Application (2021-2032)
  7. 5.2.3 Global Medical Vigilance Solutions Sales Value Share by Application (2021-2032)
6 Medical Vigilance Solutions Regional Value Analysis
  1. 6.1 Global Medical Vigilance Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Vigilance Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Vigilance Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Vigilance Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Vigilance Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Medical Vigilance Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Vigilance Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Vigilance Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Vigilance Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Vigilance Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Vigilance Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Medical Vigilance Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Vigilance Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Vigilance Solutions Sales Value Share by Country, 2025 VS 2032
7 Medical Vigilance Solutions Country-level Value Analysis
  1. 7.1 Global Medical Vigilance Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Vigilance Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Vigilance Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Vigilance Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Vigilance Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Vigilance Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Vigilance Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific Medical Vigilance Solutions Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 Accenture
  8. 8.2.1 Accenture Company Information
  9. 8.2.2 Accenture Business Overview
  10. 8.2.3 Accenture Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Accenture Medical Vigilance Solutions Product Portfolio
  12. 8.2.5 Accenture Recent Developments
  13. 8.3 PPD
  14. 8.3.1 PPD Company Information
  15. 8.3.2 PPD Business Overview
  16. 8.3.3 PPD Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PPD Medical Vigilance Solutions Product Portfolio
  18. 8.3.5 PPD Recent Developments
  19. 8.4 SGS
  20. 8.4.1 SGS Company Information
  21. 8.4.2 SGS Business Overview
  22. 8.4.3 SGS Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SGS Medical Vigilance Solutions Product Portfolio
  24. 8.4.5 SGS Recent Developments
  25. 8.5 WuXi AppTec
  26. 8.5.1 WuXi AppTec Company Information
  27. 8.5.2 WuXi AppTec Business Overview
  28. 8.5.3 WuXi AppTec Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi AppTec Medical Vigilance Solutions Product Portfolio
  30. 8.5.5 WuXi AppTec Recent Developments
  31. 8.6 Cognizant
  32. 8.6.1 Cognizant Company Information
  33. 8.6.2 Cognizant Business Overview
  34. 8.6.3 Cognizant Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cognizant Medical Vigilance Solutions Product Portfolio
  36. 8.6.5 Cognizant Recent Developments
  37. 8.7 ICON
  38. 8.7.1 ICON Company Information
  39. 8.7.2 ICON Business Overview
  40. 8.7.3 ICON Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ICON Medical Vigilance Solutions Product Portfolio
  42. 8.7.5 ICON Recent Developments
  43. 8.8 IQVIA
  44. 8.8.1 IQVIA Company Information
  45. 8.8.2 IQVIA Business Overview
  46. 8.8.3 IQVIA Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 IQVIA Medical Vigilance Solutions Product Portfolio
  48. 8.8.5 IQVIA Recent Developments
  49. 8.9 Parexel
  50. 8.9.1 Parexel Company Information
  51. 8.9.2 Parexel Business Overview
  52. 8.9.3 Parexel Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Parexel Medical Vigilance Solutions Product Portfolio
  54. 8.9.5 Parexel Recent Developments
  55. 8.10 United BioSource
  56. 8.10.1 United BioSource Company Information
  57. 8.10.2 United BioSource Business Overview
  58. 8.10.3 United BioSource Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 United BioSource Medical Vigilance Solutions Product Portfolio
  60. 8.10.5 United BioSource Recent Developments
  61. 8.11 Vial
  62. 8.11.1 Vial Company Information
  63. 8.11.2 Vial Business Overview
  64. 8.11.3 Vial Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vial Medical Vigilance Solutions Product Portfolio
  66. 8.11.5 Vial Recent Developments
  67. 8.12 Wipro
  68. 8.12.1 Wipro Company Information
  69. 8.12.2 Wipro Business Overview
  70. 8.12.3 Wipro Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wipro Medical Vigilance Solutions Product Portfolio
  72. 8.12.5 Wipro Recent Developments
  73. 8.13 PrimeVigilance
  74. 8.13.1 PrimeVigilance Company Information
  75. 8.13.2 PrimeVigilance Business Overview
  76. 8.13.3 PrimeVigilance Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 PrimeVigilance Medical Vigilance Solutions Product Portfolio
  78. 8.13.5 PrimeVigilance Recent Developments
  79. 8.14 Aixial Group
  80. 8.14.1 Aixial Group Company Information
  81. 8.14.2 Aixial Group Business Overview
  82. 8.14.3 Aixial Group Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aixial Group Medical Vigilance Solutions Product Portfolio
  84. 8.14.5 Aixial Group Recent Developments
  85. 8.15 TransPerfect
  86. 8.15.1 TransPerfect Company Information
  87. 8.15.2 TransPerfect Business Overview
  88. 8.15.3 TransPerfect Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 TransPerfect Medical Vigilance Solutions Product Portfolio
  90. 8.15.5 TransPerfect Recent Developments
  91. 8.16 ProPharma
  92. 8.16.1 ProPharma Company Information
  93. 8.16.2 ProPharma Business Overview
  94. 8.16.3 ProPharma Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ProPharma Medical Vigilance Solutions Product Portfolio
  96. 8.16.5 ProPharma Recent Developments
  97. 8.17 HCLTech
  98. 8.17.1 HCLTech Company Information
  99. 8.17.2 HCLTech Business Overview
  100. 8.17.3 HCLTech Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 HCLTech Medical Vigilance Solutions Product Portfolio
  102. 8.17.5 HCLTech Recent Developments
  103. 8.18 QbD Group
  104. 8.18.1 QbD Group Company Information
  105. 8.18.2 QbD Group Business Overview
  106. 8.18.3 QbD Group Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  107. 8.18.4 QbD Group Medical Vigilance Solutions Product Portfolio
  108. 8.18.5 QbD Group Recent Developments
  109. 8.19 Quanticate
  110. 8.19.1 Quanticate Company Information
  111. 8.19.2 Quanticate Business Overview
  112. 8.19.3 Quanticate Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Quanticate Medical Vigilance Solutions Product Portfolio
  114. 8.19.5 Quanticate Recent Developments
  115. 8.20 Qinecsa Solutions
  116. 8.20.1 Qinecsa Solutions Company Information
  117. 8.20.2 Qinecsa Solutions Business Overview
  118. 8.20.3 Qinecsa Solutions Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Qinecsa Solutions Medical Vigilance Solutions Product Portfolio
  120. 8.20.5 Qinecsa Solutions Recent Developments
  121. 8.21 Veristat
  122. 8.21.1 Veristat Company Information
  123. 8.21.2 Veristat Business Overview
  124. 8.21.3 Veristat Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Veristat Medical Vigilance Solutions Product Portfolio
  126. 8.21.5 Veristat Recent Developments
  127. 8.22 Veeda
  128. 8.22.1 Veeda Company Information
  129. 8.22.2 Veeda Business Overview
  130. 8.22.3 Veeda Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Veeda Medical Vigilance Solutions Product Portfolio
  132. 8.22.5 Veeda Recent Developments
  133. 8.23 Tigermed
  134. 8.23.1 Tigermed Company Information
  135. 8.23.2 Tigermed Business Overview
  136. 8.23.3 Tigermed Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Tigermed Medical Vigilance Solutions Product Portfolio
  138. 8.23.5 Tigermed Recent Developments
  139. 8.24 Clarivate
  140. 8.24.1 Clarivate Company Information
  141. 8.24.2 Clarivate Business Overview
  142. 8.24.3 Clarivate Medical Vigilance Solutions Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Clarivate Medical Vigilance Solutions Product Portfolio
  144. 8.24.5 Clarivate Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst